LDS/Medical Tests/Transthyretin (TTR) Gene Mutation Analysis

Transthyretin (TTR) Gene Mutation Analysis

The TTR gene that is located in the long (q) arm of chromosome 18 at position 12.1 and encodes for transthyretin protein. Transthyretin, 55 kDa homo-tetrameric protein, also known as prealbumin is a primary transport protein for thyroxine and retinol (vitamin A). The structure of transthyretin is rich in β-sheets with four binding sites: two for thyroxine and two for the retinol-RBP complex. It is synthesized in the liver, choroid plexus and retinal pigment epithelium for secretion into the bloodstream, cerebrospinal fluid and the eye, respectively. Mutation or pathogenic variants in TTR gene have been identified in transthyretin amyloidosis, senile systemic amyloidosis and carpal tunnel syndrome. Pathogenic variants in TTR gene include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Most of the TTR gene mutations that cause transthyretin amyloidosis are thought to alter the structure of transthyretin, impairing its ability to bind to other transthyretin proteins and altering its normal function. Transthyretin amyloidosis is an autosomal dominant disorder resulting in the deposition of insoluble amyloid fibrils around peripheral nerves and in various tissues, including the heart muscle. There are three major forms of transthyretin amyloidosis, which are distinguished by their symptoms and the organs they affect.

The neuropathic form of transthyretin amyloidosis primarily affects the peripheral and autonomic nervous systems, resulting in peripheral neuropathy and difficulty controlling bodily functions. The leptomeningeal form of transthyretin amyloidosis primarily affects the central nervous system and may result in hemorrhagic stroke, an accumulation of fluid in the brain (hydrocephalus), impaired motor coordination (ataxia), muscle stiffness and weakness (spastic paralysis), seizures, and loss of intellectual function (dementia). The cardiac form of transthyretin amyloidosis may cause abnormal heartbeat (arrhythmia), an enlarged heart (cardiomegaly), hypertension, heart failure and death. The cardiac form may be confused with familial hypertrophic cardiomyopathy (HCM) which should be considered in the diagnostic work-up.

Carpal tunnel syndrome is caused by neuropathy that leads to pain and numbness or tingling (paresthesia) primarily in the wrist and hand. Mutations in TTR may result in carpal tunnel syndrome by causing amyloid deposition in the median nerve resulting in its impingement in the wrist.

  • Clinical diagnosis of transthyretin-associated familial amyloidosis
  • As an aid in diagnosis of senile systemic amyloidosis
  • As an aid in diagnosis of carpal tunnel syndrome
  • Differentiation between cardiac amyloidosis and other cardiomyopathies
  • Carrier testing in at-risk family members
  • Prenatal diagnosis in families with a known pathogenic variant
Mutation or pathogenic variants in TTR gene would be consistent with diagnosis of transthyretin-associated familial amyloidosis. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative for mutations analyzed (No pathogenic variant or mutation detected)

Targeted sequence by next-generation sequencing (NGS) for pathogenic variants, deletions or duplications by PCR or multiplex ligation-dependent probe amplification (MLPA) analysis.

Whole blood (EDTA), buccal swab.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Tissue biopsy with cytochemistry and/or immunohistochemistry (anti-TTR) to identify amyloid deposition, Complete blood count, electrolytes, renal function tests, electrospray ionization mass spectrometry, radiolabeled P-component scanning, 2-dimensional echocardiography, electrocardiography, CT scan, cardiac MRI.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Rev Esp Cardiol (Engl Ed). 2017;70: 991-1004. [PMID: 28870641]
  • Neurol Clin Pract. 2019 Aug;9(4):309-313. [PMID: 31583185]
  • Amyloid. 2017;24: 87-91. [PMID: 28475415]
  • Front Physiol. 2019;10: 5. [PMID: 30733681]
  • Amyloid. 2016;23(1):58-63. [PMID: 26852880]
  • Trends Cardiovasc Med. 2018; 28: 10-21. [PMID: 28739313]
  • J Neurol Neurosurg Psychiatry. 1993;56: 694-7. [PMID: 8509786]
  • GeneReviews® [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1194/
  • Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/TTR#